Previous 10 | Next 10 |
Gainers: Eiger BioPharmaceuticals (EIGR) +36%. Cyteir Therapeutics (CYT) +30%. PAVmed (PAVM) +28%. Cingulate (CING) +26%. Bone Biologics (OTCPK:BBLG) +22%. Losers: Incannex Healthcare Limited (IXHL) -12%. Jounce Therapeutics (JNCE) -9%. Rapid Micro Biosystems (RPID) -...
Gainers: Incannex Healthcare Limited (NASDAQ:IXHL) +176%. Revelation Biosciences (NASDAQ:REVB) +34%. Kaival Brands Innovations (NASDAQ:KAVL) +29%. Rapid Micro Biosystems (NASDAQ:RPID) +25%. Summer Infant (NASDAQ:SUMR) +22%. Kingsoft Cloud (NASDAQ:KC) +21%. RLX Technology (NYSE:RLX) +20%. Sone...
The following slide deck was published by Rapid Micro Biosystems, Inc. in conjunction with this event. For further details see: Rapid Micro Biosystems (RPID) Investor Presentation - Slideshow
The following slide deck was published by Rapid Micro Biosystems, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Rapid Micro Biosystems, Inc. 2021 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q4 2021 Earnings Call Mar 04, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Rapid Micro Biosystems, Inc. (RPID) Q4 2021 Earnings Call Tran...
Rapid Micro Biosystems Inc. (RPID) Q4 2021 Earnings Conference Call March 4, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Rob Spignesi - President and Chief Executive Officer Sean Wirtjes - Chief Financial Officer Con...
Rapid Micro Biosystems press release (NASDAQ:RPID): Q4 GAAP EPS of -$0.35. Revenue of $5.21M (-0.6% Y/Y). For further details see: Rapid Micro Biosystems GAAP EPS of -$0.35, revenue of $5.21M
Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and commercial revenue of $21.6 million Reaffirms full year 2022 commercial revenue outlook range of $27 milli...
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of heal...
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing...
News, Short Squeeze, Breakout and More Instantly...
Rapid Micro Biosystems Inc. Company Name:
RPID Stock Symbol:
NASDAQ Market:
Rapid Micro Biosystems Inc. Website:
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...